arrow
D

David R. Raleigh

University of California San Francisco
H指数:53
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective consecutive genomic profiling defines the distribution of meningioma molecular alterations across demographic groups

前瞻性连续基因组分析定义了不同人口统计群体中脑膜瘤分子变异的分布

2026-08-190
PRE
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways

STING激活通过炎症性细胞死亡通路诱导脑膜瘤中的细胞毒性及免疫反应

2026-02-120
OAAI
The 2024 Brain Tumor Segmentation Challenge Meningioma Radiotherapy (BraTS-MEN-RT) dataset

2024脑肿瘤分割挑战脑膜瘤放射治疗 (BraTS-MEN-RT) 数据集

2026-01-270
OA
Novel insights into meningioma brain invasion with spatial transcriptomic profiling

脑膜瘤脑侵袭的新见解:空间转录组学分析

2026-01-040
OAAI
Stereotactic radiosurgery for recurrent primary and metastatic central nervous system malignancies in the pediatric population

立体定向放射外科治疗儿童复发性原发性及转移性中枢神经系统恶性肿瘤

2026-01-010
OA
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30

在神经肿瘤学会成立30周年之际,回顾科学增长与创新

2025-11-040
PRE
Bitopic inhibitors of mTORC1 cooperate with inhibitors of mitogen-activated protein kinase kinase to drive cytotoxicity in glioblastoma

mTORC1双位点抑制剂与丝裂原活化蛋白激酶激酶抑制剂协同作用,以驱动胶质母细胞瘤的细胞毒性。

2025-11-010
OAAI
Development of in vivo CRISPR interference screens in diffuse midline glioma xenografts to identify genetic vulnerabilities controlling responses to radiation therapy

在弥漫性中线胶质瘤异种移植模型中开发体内CRISPR干扰筛选,以识别调控辐射治疗反应的遗传脆弱性

2025-11-010
OAAI
A coordinated care model for multidisciplinary meningioma treatment and research

多学科脑膜瘤治疗与研究的协同护理模型

2025-11-010
OAAI